Post-earnings recap
Reported
Wed, Aug 2, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Teladoc Health reported a loss that was worse than expected, leading to a decline in stock price by 5.53%. The lack of revenue figures and management commentary adds uncertainty about the company's performance and future outlook. Investors may be cautious as they await more information.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.28 | N/A | -10.47% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.